Clinical trials
Neoplasms trials in Austria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
156 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2005 | 4 |
| 2006 | 5 |
| 2007 | 5 |
| 2008 | 8 |
| 2009 | 5 |
| 2010 | 7 |
| 2011 | 8 |
| 2012 | 9 |
| 2013 | 4 |
| 2014 | 8 |
| 2015 | 7 |
| 2016 | 7 |
| 2017 | 6 |
| 2018 | 7 |
| 2019 | 12 |
| 2020 | 8 |
| 2021 | 12 |
| 2022 | 6 |
| 2023 | 8 |
| 2024 | 9 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 80 |
| Active, not recruiting | 27 |
| Recruiting | 21 |
| Terminated | 16 |
| Unknown status | 8 |
| Not yet recruiting | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 13 |
| Amgen | 12 |
| Medical University of Vienna | 12 |
| Novartis Pharmaceuticals | 10 |
| Hoffmann-La Roche | 5 |
| AstraZeneca | 4 |
| Bayer | 3 |
| Bristol-Myers Squibb | 3 |
| GlaxoSmithKline | 3 |
| Pfizer | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 156 |
| Breast Neoplasms | 15 |
| Carcinoma, Non-Small-Cell Lung | 13 |
| Neoplasm Metastasis | 13 |
| Neoplasms by Site | 11 |
| Prostatic Neoplasms | 9 |
| Brain Neoplasms | 8 |
| Colorectal Neoplasms | 8 |
| Leukemia | 7 |
| Lung Neoplasms | 7 |
Trials
Showing 51 to 75 of 156. Each trial links to its page on Pharma Observatory.
56 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.